Blue Jet Healthcare (BLUEJET) | Financial Analysis & Statements
Blue Jet Healthcare Ltd. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
3.5B
Gross Profit
1.7B
48.44%
Operating Income
1.2B
32.50%
Net Income
911.7M
25.70%
EPS (Diluted)
₹5.26
Balance Sheet Metrics
Total Assets
14.2B
Total Liabilities
2.8B
Shareholders Equity
11.3B
Debt to Equity
0.25
Cash Flow Metrics
Operating Cash Flow
539.0M
Free Cash Flow
-54.6M
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Blue Jet Healthcare Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 10.3B | 7.1B | 7.2B | 6.8B | 5.0B |
| Cost of Goods Sold | 4.7B | 3.2B | 3.4B | 2.9B | 1.8B |
| Gross Profit | 5.6B | 3.9B | 3.8B | 3.8B | 3.2B |
| Gross Margin % | 54.2% | 54.9% | 52.2% | 56.7% | 64.6% |
| Operating Expenses | |||||
| Research & Development | 15.5M | - | - | - | - |
| Selling, General & Administrative | 317.0M | 272.5M | 327.0M | 364.3M | 308.2M |
| Other Operating Expenses | 611.1M | 594.1M | 630.5M | 538.2M | 431.5M |
| Total Operating Expenses | 943.6M | 866.6M | 957.5M | 902.5M | 739.7M |
| Operating Income | 3.6B | 2.0B | 1.9B | 2.3B | 1.9B |
| Operating Margin % | 35.1% | 28.5% | 26.9% | 33.5% | 37.6% |
| Non-Operating Items | |||||
| Interest Income | 54.0M | 28.2M | 5.9M | 4.4M | 6.2M |
| Interest Expense | 960.0K | 1.6M | 13.6M | 32.8M | 46.9M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 4.1B | 2.2B | 2.2B | 2.4B | 1.8B |
| Income Tax | 1.0B | 563.4M | 565.8M | 616.4M | 488.7M |
| Effective Tax Rate % | 24.8% | 25.6% | 26.1% | 25.3% | 26.5% |
| Net Income | 3.1B | 1.6B | 1.6B | 1.8B | 1.4B |
| Net Margin % | 29.7% | 23.1% | 22.2% | 26.8% | 27.4% |
| Key Metrics | |||||
| EBITDA | 4.1B | 2.4B | 2.4B | 2.7B | 2.1B |
| EPS (Basic) | ₹17.59 | ₹9.44 | ₹9.23 | ₹10.47 | ₹7.98 |
| EPS (Diluted) | ₹17.59 | ₹9.44 | ₹9.23 | ₹10.47 | ₹7.98 |
| Basic Shares Outstanding | 173465425 | 173465425 | 173465425 | 173465425 | 173465425 |
| Diluted Shares Outstanding | 173465425 | 173465425 | 173465425 | 173465425 | 173465425 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Blue Jet Healthcare Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 329.8M | 409.5M | 654.4M | 753.7M | 611.3M |
| Short-term Investments | 2.5B | 2.7B | 2.0B | 962.9M | 368.4M |
| Accounts Receivable | 3.5B | 1.8B | 2.4B | 2.3B | 1.4B |
| Inventory | 2.6B | 1.3B | 1.3B | 1.1B | 1.2B |
| Other Current Assets | 1.7M | 612.3M | - | - | - |
| Total Current Assets | 10.1B | 7.1B | 6.7B | 5.5B | 3.9B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 212.6M | 16.4M | 51.8M | 35.2M | 28.6M |
| Goodwill | 5.1M | 2.0M | 410.0K | 0 | 10.0K |
| Intangible Assets | 5.1M | 2.0M | 410.0K | - | 10.0K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 166.2M | -30.0K | -20.0K | - | - |
| Total Non-Current Assets | 4.1B | 3.5B | 2.0B | 1.7B | 1.5B |
| Total Assets | 14.2B | 10.6B | 8.6B | 7.1B | 5.4B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 890.5M | 303.0M | 537.8M | 565.5M | 595.3M |
| Short-term Debt | 34.6M | 12.3M | 18.9M | 40.2M | 229.3M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 23.2M | 32.5M | 15.9M | 16.8M | 92.6M |
| Total Current Liabilities | 2.6B | 2.1B | 1.7B | 1.7B | 1.6B |
| Non-Current Liabilities | |||||
| Long-term Debt | 165.3M | 3.8M | 15.5M | 133.0M | 286.8M |
| Deferred Tax Liabilities | 72.9M | 31.6M | 10.2M | 2.6M | 13.8M |
| Other Non-Current Liabilities | - | 10.0K | - | - | - |
| Total Non-Current Liabilities | 285.1M | 76.6M | 67.0M | 173.3M | 333.5M |
| Total Liabilities | 2.8B | 2.1B | 1.8B | 1.9B | 2.0B |
| Equity | |||||
| Common Stock | 346.9M | 346.9M | 346.9M | 346.9M | 99.1M |
| Retained Earnings | 11.0B | 8.1B | 6.5B | 4.9B | 3.2B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 11.3B | 8.5B | 6.8B | 5.2B | 3.4B |
| Key Metrics | |||||
| Total Debt | 199.9M | 16.1M | 34.4M | 173.2M | 516.2M |
| Working Capital | 7.5B | 5.0B | 4.9B | 3.7B | 2.3B |
Balance Sheet Composition
Blue Jet Healthcare Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 4.1B | 2.2B | 2.2B | 2.4B | 1.8B |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -3.1B | 259.0M | -295.6M | -714.8M | -779.2M |
| Operating Cash Flow | 899.3M | 2.5B | 1.9B | 1.7B | 1.1B |
| Investing Activities | |||||
| Capital Expenditures | -795.0M | -1.7B | -588.6M | -214.6M | -490.1M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | -1.3B | -1.3B | -1.1B | -550.0M | -101.7M |
| Investment Sales | 1.7B | 393.4M | 230.4M | 0 | 25.3M |
| Investing Cash Flow | -403.9M | -2.6B | -1.5B | -764.6M | -513.4M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -173.5M | -20.0K | -20.0K | -20.0K | -20.0K |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | - | - | 0 | -292.4M | -80.1M |
| Financing Cash Flow | -173.5M | -20.0K | -20.0K | -525.6M | -221.9M |
| Free Cash Flow | -341.2M | 669.6M | 822.8M | 1.2B | 801.2M |
| Net Change in Cash | 321.9M | -133.5M | 412.3M | 455.9M | 379.0M |
Cash Flow Trend
Blue Jet Healthcare Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
23.87
Forward P/E
22.70
Price to Book
5.56
Price to Sales
6.64
PEG Ratio
-0.77
Profitability Ratios
Profit Margin
27.88%
Operating Margin
21.26%
Return on Equity
26.93%
Return on Assets
21.53%
Financial Health
Current Ratio
3.93
Debt to Equity
1.64
Beta
0.37
Per Share Data
EPS (TTM)
₹16.90
Book Value per Share
₹72.50
Revenue per Share
₹60.71
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| BLUEJET | 70.0B | 23.87 | 5.56 | 26.93% | 27.88% | 1.64 |
| Biocon | 566.5B | 71.84 | 1.68 | 3.66% | 3.59% | 50.02 |
| OneSource Specialty | 202.8B | 936.63 | 3.11 | -0.31% | 1.42% | 21.93 |
| Concord Biotech | 106.3B | 34.14 | 5.86 | 20.50% | 26.97% | 0.09 |
| Supriya Lifescience | 51.7B | 27.94 | 4.78 | 18.86% | 25.19% | 0.48 |
| Zota Health Care | 39.4B | -62.53 | 12.61 | -24.83% | -15.37% | 56.90 |
Financial data is updated regularly. All figures are in the company's reporting currency.





